Atea Pharmaceuticals, Inc. (AVIR)

Last Price: 21.32 (2021-05-07)

Company Description

Atea Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on discovering, developing and commercializing antiviral therapeutics to improve the lives of patients suffering from life-threatening viral infections. Atea Pharmaceuticals Inc. is based in BOSTON.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $48.63M
Net Income (Most Recent Fiscal Year) $-10.95M
PE Ratio (Current Year Earnings Estimate) 2.56
PE Ratio (Trailing 12 Months) --
PEG Ratio (Long Term Growth Estimate) --
Price to Sales Ratio (Trailing 12 Months) --
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 3.22
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) --
Pre-Tax Margin (Trailing 12 Months) -22.51%
Net Margin (Trailing 12 Months) --
Return on Equity (Trailing 12 Months) --
Return on Assets (Trailing 12 Months) --
Current Ratio (Most Recent Fiscal Quarter) 2.73
Quick Ratio (Most Recent Fiscal Quarter) 2.73
Debt to Common Equity (Most Recent Fiscal Quarter) 0.00
Inventory Turnover (Trailing 12 Months) --
Book Value per Share (Most Recent Fiscal Quarter) $6.63
Earnings per Share (Most Recent Fiscal Quarter) --
Earnings per Share (Most Recent Fiscal Year) $-0.51
Diluted Earnings per Share (Trailing 12 Months) --
Stock
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Common Shares Outstanding 82.74M
Free Float 78.65M
Market Capitalization $1.76B
Average Volume (Last 20 Days) 1.10M
Beta (Past 60 Months) --
Percentage Held By Insiders (Latest Annual Proxy Report) 4.94%
Percentage Held By Institutions (Latest 13F Reports) 57.56%
Annual Dividend (Based on Last Quarter) $0.00
Dividend Yield (Based on Last Quarter) 0.00%